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Abstract
Background: Exposure to intense sound or high doses of aminoglycoside antibiotics can increase hearing thresholds,
induce cochlear dysfunction, disrupt hair cell morphology and promote hair cell death, leading to permanent hearing loss.
When the two insults are combined, synergistic ototoxicity occurs, exacerbating cochlear vulnerability to sound exposure.
The underlying mechanism of this synergism remains unknown. In this study, we tested the hypothesis that sound exposure
enhances the intra-cochlear trafficking of aminoglycosides, such as gentamicin, leading to increased hair cell uptake of
aminoglycosides and subsequent ototoxicity.
Methods: Juvenile C57Bl/6 mice were exposed to moderate or intense sound levels, while fluorescently-conjugated or
native gentamicin was administered concurrently or following sound exposure. Drug uptake was then examined in cochlear
tissues by confocal microscopy.
Results: Prolonged sound exposure that induced temporary threshold shifts increased gentamicin uptake by cochlear hair
cells, and increased gentamicin permeation across the strial blood-labyrinth barrier. Enhanced intra-cochlear trafficking and
hair cell uptake of gentamicin also occurred when prolonged sound, and subsequent aminoglycoside exposure were
temporally separated, confirming previous observations. Acute, concurrent sound exposure did not increase cochlear
uptake of aminoglycosides.
Conclusions: Prolonged, moderate sound exposures enhanced intra-cochlear aminoglycoside trafficking into the stria
vascularis and hair cells. Changes in strial and/or hair cell physiology and integrity due to acoustic overstimulation could
increase hair cell uptake of gentamicin, and may represent one mechanism of synergistic ototoxicity.
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Introduction
Aminoglycosides are critical for treating life-threatening Gram-
negative bacterial infections, e.g., bacterial sepsis and meningitis
[1,2]. Yet, aminoglycosides also induce cytotoxicity in the kidney
and cochlea. After systemic administration, inner ear sensory hair
cells and kidney proximal tubule cells preferentially retain
aminoglycosides [3], display greater pharmacological sensitivity
and cytotoxicity to these drugs than other cell types in the body
[review by Rybak et al.[4]].
Acoustic trauma occurs in many environments, including
occupational (e.g., industrial, military), or recreational (e.g.,
musical concerts, hunting) settings. Sound trauma-induced
cochlear pathologies include increased endocytosis, vacuolation,
mitochondrial lesions, elevation of intracellular Ca
2+ concentra-
tions and the generation of reactive oxygen species that can lead to
hair cell death and permanent hearing loss [5,6,7]. Moderate
acoustic damage can also be reversible, as temporary threshold
shifts (TTS), due to acute exposure to high sound levels or chronic
exposure to intermediate sound levels that induce reversible
physiological changes in hair cells and the blood-labyrinth barrier
[8,9,10].
Combining acoustic and ototoxic insults leads to synergistic
ototoxicity, that is, potentiation of aminoglycoside-induced
ototoxicity by acoustic trauma. This was first observed in the
1960s when animals receiving aminoglycosides appeared to be
more susceptible to noise-induced hearing loss [11] and confirmed
by subsequent studies [12,13,14,15]. The same ototoxic mecha-
nism is likely responsible for the increased deafness risk in pre-term
infants from neonatal intensive care units [16,17] and in wounded
soldiers [18,19,20,21,22]. Multiple cochlear events may be
responsible for sound-and-drug induced synergy. Aminoglycosides
slowly permeate through the mechanoelectrical transduction
(MET) channel on the apical surface of hair cells, blocking the
rapid depolarizing transduction current of MET channels,
preventing functional ion channel kinetics [23,24]. An increase
in the open probability of, and current through, MET channels
during sound exposure could increase aminoglycoside uptake, and
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Alternatively, pathological modifications, including variation in
vascular permeability [25], in the cochlear lateral wall are induced
by acoustic overstimulation. These modifications may increase
aminoglycoside permeation into endolymph that bathes the apical
surfaces of hair cells. Trans-strial trafficking of systemic amino-
glycosides into endolymph is considered to be a primary route for
aminoglycoside loading of sensory hair cells [26]. In this study, we
hypothesized that sound exposure enhances the intra-cochlear
trafficking of aminoglycosides, and consequently hair cell uptake of
aminoglycosides.
To test the hypothesis, mice were exposed to moderate or
intense sound levels either concurrently or prior to gentamicin
treatment. Fluorescently-conjugated (GTTR) or native gentamicin
was administered during or after a variety of sound exposures.
Here, we report that (i) chronic acoustic overstimulation increased
hair cell uptake of systemic aminoglycosides; (ii) acute, concurrent
sound and systemic aminoglycoside exposure did not increase hair
cell uptake of aminoglycosides; and (iii) broader examination of
cochlear tissues revealed that marginal cells in the stria vascularis
exhibit increased gentamicin uptake following chronic, sound-
induced TTS, representing one potential mechanism for sound-
then-drug induced ototoxic synergy.
Results
Prolonged prior sound exposure enhanced gentamicin
uptake in hair cells
In this study, to determine if prolonged wide-band noise (WBN)
exposure increased gentamicin uptake, mice were exposed to WBN
for 18 hours (86 dB SPL, over 3 days, 6 h per day). A moderate
sound level was intentionally selected to mimic the environment in
neonatal intensive care units [16]. After sound exposure on the 3
rd
day, mice were allowed to rest for 30 minutes prior to i.p. injection
with GTTR (2 mg/kg). Mice were then kept in quiet for another 30
minutes prior to cochlear tissue collection. In 3 out of 4 sound-
exposedmice(Fig. 1E–H), robust GTTR fluorescence wasobserved
inOHCs inboth middleand basalregionsofthecochlea,compared
to weaker GTTR fluorescence in non-sound-exposed control mice
(Fig. 1A–D). GTTR uptake in some sound-exposed OHCs was very
robust that some pixels were saturated in intensity, i.e., the
fluorescence intensity in these pixels was likely underestimated.
The increase of fluorescence intensities was statistically significant
(Fig. 1I and Fig. 3F). Thus, prolonged prior sound exposure greatly
enhanced GTTR uptake in OHCs, although with some inter-
animal variation (summarized in Fig. 1I). Similar results were
observed when GTTR treatment was overlapped by the final 30-
min sound exposure on day 3 (Figure S1).
We repeated this experiment using prolonged sound exposure
and native gentamicin, followed by immunofluorescence. The
monoclonal gentamicin antisera used in this study produced a
monotonic increase in fluorescence intensity with increasing
gentamicin dose (Figure S2). Gentamicin (200 mg/kg i.p.) was
given to mice for 30-min following prolonged sound exposure
(18 hour WBN at 86 dB SPL over 3 days, 6 h per day). Control
animals were exposed to gentamicin only for 30 min. In 3 out of 4
sound-exposed mice, OHCs displayed greater gentamicin immu-
nofluorescence compared to non-sound-exposed mice (Fig. 2A–C
and Fig. 3G). Neither hair bundle damage, nor nuclear
abnormalities, were detectable in phalloidin (Fig. 2D) and DAPI-
stained (Fig. 2E) whole mounts from prolonged sound-exposed
cochleae. This paradigm of sound exposure induced significant
TTS at 8, 16 and 32 kHz, and substantial recovery 4 weeks later
(Fig. 2F). Together with earlier experiments, these data indicate
that chronic, moderate prior sound exposure can increase hair cell
uptake of gentamicin.
To investigate whether sound stimulation itself increased drug
uptake by hair cells, we presented WBN (100 dB SPL) for a shorter
3 hour period in an open field, and concurrently administered
GTTR (i.p.) systemically. Concurrent sound and GTTR exposure
for 3 hours did not enhance OHC uptake of GTTR in middle or
basal cochlear coils (Fig. 3A). To rule out the possibility that
GTTR trafficking mechanisms were saturated between the strial
vasculature and the organ of Corti, additional experiments were
done by reducing the GTTR level to 1 mg/kg (Fig. 3B), or
reducing the GTTR (2 mg/kg) exposure period to 30 minutes
(Fig. 3C). Neither exposure paradigm altered the degree of GTTR
uptake by sound-exposed OHCs compared to controls.
We then used closed tube sound delivery of octave-wide band
noise (OBN), and to provide frequency-specific sound exposure.
The OBN was centered at 12 kHz, corresponding to a cochlear
location of 33% from the apex [27], approximately the middle coil
region of the cochlea, and OHCs were imaged. A 30-minute
concurrent sound and GTTR exposure did not enhance GTTR
uptake by OHCs, at either moderate (76 dB SPL, Fig. 3D) or
intense (100 dB SPL, Fig. 3E) sound levels over control mice. In
addition, a frequency-specific enhancement of GTTR uptake by
OHCs was not observed, i.e., similar fluorescence levels occurred
in OHCs from the middle coil and basal coil in sound-exposed
ears. These experiments were repeated using gentamicin (200 mg/
kg i.p.), and no differential gentamicin immunofluorescence was
observed between sound-exposed and control ears, nor between
middle and basal coils (data not shown).
Heterogeneous enhancement of gentamicin uptake by
strial cells
Typically, the most intense gentamicin immunofluorescence in
control (non-sound-exposed) strial tissues was observed in the strial
vasculature (Fig. 4C), as for GTTR [26,28]. When we examined
the stria vascularis after chronic moderate sound exposure (same
animals as in Fig. 2), a subpopulation of marginal cells exhibited
more intense gentamicin immunofluorescence (Fig. 4B) compared
to adjacent marginal cells or marginal cells from control (non-
sound-exposed) mice (Fig. 4A). In addition, the fluorescent
intensity of the vasculature in sound-exposed stria vasculari
(Fig. 4D) was reduced compared to control (non-sound-exposed)
strial tissues (Fig. 4C); and the most intense fluorescence in sound-
exposed strial vasculari was localized in individual groups of
marginal cells (Fig. 4B). Furthermore, chronic sound exposure also
increased the diameter of strial blood vessels (i.e. vasodilation) in
the same strial regions with intensely-labeled marginal cells
compared to adjacent strial regions without intensely-labeled
marginal cells or in strial tissues from non-sound-exposed animals
(Fig. 4E, F and G).
Capillary or blood vessel diameter is highly correlated to strial
blood flow, an attribute that can be consistently monitored in vivo,
and can vary during sound exposure [29]. Noise-induced
variation in blood flow within the strial vasculature is transient,
and eventually recovers to pre-exposure values [30] within hours.
Mice were exposed to 100 dB SPL octave-wide band noise (8–
16 kHz) for 6 hours. The next morning, to allow recovery of any
transient diameter changes in strial vessels, mice were injected
with GTTR (2 mg/kg i.p.), and cochlear tissues collected 30
minutes later. In these mice, increased GTTR fluorescence was
observed in individual groups of marginal cells (Fig. 5B),
compared to non-sound-exposed control strial cells (Fig. 5A).
Directly below these intensely fluorescent marginal cells, the
intra-strial tissues also showed a corresponding increase in GTTR
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PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e19130Figure 1. Prior prolonged sound exposure increased GTTR uptake in OHCs. GTTR (2 mg/kg) was injected i.p. for 30 minutes after an 18-
hour WBN exposure over 3 days (6 hours per day, 86 dB SPL). Increased GTTR fluorescence intensities were observed in OHCs from the middle coil of
cochleae from the majority of individual animals (E–H), compared to control (non-sound exposed) animals (A–D). Scale bar in H is 20 mm. I: The
fluorescence intensity of the cuticular plate region of each OHC was scored from each confocal stack. Four stacks were imaged from each animal. Two
sites were from the middle coil (circle) and 2 sites were from the basal coil (square). OHCs from 3 of 4 examined animals exhibited robust increase in
GTTR fluorescence after prolonged prior sound exposure, compared to control OHCs (n=4). Horizontal lines depict the group mean of fluorescence
intensity. Solid line: middle coil; dashed line: basal coil. The Mann-Whitney nonparametric test indicated that prolonged sound exposure exerted a
statistically significant effect on GTTR fluorescence in OHC cuticular plates in both middle coil (p,0.001) and basal coil (p,0.01) locations compared
to control cuticular plates.
doi:10.1371/journal.pone.0019130.g001
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nor a decrease in fluorescence in the strial vasculature
(endothelial cells). These regions of increased drug uptake in
sound-exposed tissue were observed in 3 of 8 sound-exposed
cochleae, using GTTR or gentamicin (immuno)fluorescence. A
retrospective examination of cochleae in Fig. 1, also revealed
sound-induced heterogeneous uptake of GTTR by strial cells in
cochleae that displayed robust GTTR uptake in OHCs. This
suggests that chronic sound exposure or sound-induced trauma
can enhance aminoglycoside trafficking into the stria vascularis,
as well as hair cells, hours after cessation of exposure to loud
sounds.
Discussion
Preventing the ototoxic synergy of noise and aminoglycosides
can be best achieved by using non-ototoxic bactericidal drugs, and
by attenuating perceived sound levels when life-saving aminogly-
coside therapy is required. However, this is not always possible,
e.g., prior exposure to blasts and explosions followed by wound
Figure 2. Prolonged sound exposure increased gentamicin uptake in OHCs. Gentamicin (200 mg/kg) was injected i.p. for 30 minutes
following an 18-hour WBN exposure over 3 days (6 hours per day, 86 dB SPL). Increased gentamicin immunofluorescence was generally observed in
basal sound-exposed OHCs (B) compared to control (non-sound exposed) animals (A). Scale bar in A=20 mm. C: The immunofluorescence intensity
of OHC cuticular plates from either middle coils (circle) or basal coils (square) were increased in 3 of 4 animals after chronic moderate sound exposure
(p,0.05, paired t-test). Immunoprocessing for each batch of animals were carried out simultaneously for each pair-wise comparison. Chronic
moderate sound exposure did not disrupt hair bundle morphology determined by phalloidin labeling (D, red), nor nuclei integrity by DAPI staining
(E, blue); green, anti-gentamicin IgG. Scale bar =20 mm. F: This sound exposure paradigm produced a temporary elevation in hearing thresholds
(n=6) that largely recovered within 4 weeks. Error bar is s.e.m. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0019130.g002
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chronic exposure to moderate sound levels and aminoglycosides
by pre-term infants in intensive care units [16]. Therefore, it is
critical to understand how sound exposure can enhance the
unwanted ototoxic side-effects of the clinically-indispensable
aminoglycosides.
Previous animal studies of sound and aminoglycoside synergy
measured hearing sensitivity and constructed cytocochleograms of
hair cell survival [13,14]; they did not measure drug uptake in vivo.
Gentamicin is present within OHCs before onset of drug-induced
ototoxicity [31], emphasizing the need to identify and prevent the
underlying mechanism of drug trafficking. Since prior sound
exposures that induce TTS (or greater pathologies) can increase
hair cell uptake of gentamicin in vivo, interventions that inhibit
trafficking of aminoglycosides into the cochlea likely represent one
potential clinical strategy to prevent sound-then-drug ototoxic
synergism.
Previous studies of simultaneous sound and drug exposure took
place over many days, and are different from the acute concurrent
experimental paradigms used here. In a study by Collins [32]
showed that if sound exposure was given on the first day of a 10-
day gentamicin course there was considerable loss of hair cells; if
given on the 10
th day the loss was several times less. Other studies
report ototoxic synergy when aminoglycoside treatment followed
acoustic overstimulation, but not when sound exposure followed
drug treatment [see review by Li and Steyger [17]]. We believe
that any weak synergistic effect observed in a drug-then-sound
paradigm, as by Hayashida and colleagues [33], is due to a
compound effect between residual aminoglycoside-induced dam-
age and subsequent sound exposure.
Despite attempts to understand the impact of noise on
permeability variation of blood-labyrinth barrier [such as [10]],
moderate sound levels that more relevant to clinical situations
were rarely tested. In this study, we demonstrate that chronic or
Figure 3. Concurrent sound exposure did not increase GTTR uptake in OHCs. The intensity of GTTR fluorescence in OHC cuticular plates
was scored from either middle or basal coils, and data are in box and whisker plots, which respectively represent the lower and upper quartiles, and
the minimum and maximum of each data set. A: WBN (100 dB SPL) and GTTR (2 mg/kg, i.p.) simultaneously administered for 3 hours. B: WBN
(100 dB SPL) and GTTR (1 mg/kg, i.p.) co-administered for 3 hours. C: GTTR (2 mg/kg, i.p.) administered 30 minutes prior to the end of 3 hour WBN
(100 dB SPL) exposure. Sound was delivered in open field in A–C, and GTTR fluorescence obtained from the left cochlea only. D: OBN of 76 dB SPL
(centered at 12 kHz) and GTTR (2 mg/kg, i.p.) co-administered for 30 minutes. E: OBN of 100 dB SPL (centered at 12 kHz) and GTTR (2 mg/kg, i.p.) co-
administered for 30 minutes. Sound was delivered in a closed tube system in D and E, while GTTR fluorescence intensities were compared between
sound-exposed left ears and non-sound exposed right ears. F: GTTR (2 mg/kg) was injected i.p. for 30 minutes after an 18-hour 86-dB-SPL WBN
exposure over 3 days (same dataset as Fig. 1I). G: Gentamicin (200 mg/kg) was injected i.p. for 30 minutes following an 18-hour 86-dB-SPL WBN
exposure over 3 days (same dataset as Fig. 2C). n.s.= not significant, by either unpaired (A, B, C and F) or paired (D, E and G) t-test. Experiments were
not compared across conditions/figure panels.
doi:10.1371/journal.pone.0019130.g003
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e19130damaging sound exposures at moderate levels can enhance
cochlear uptake of gentamicin in vivo, which has not been
previously shown (to our knowledge). GTTR enters hair cells
within 30 minutes after systemic administration without sound
stimulation [26]. Exogenous stimulation such as administration of
vasoactive peptides, e.g., histamine, can significantly reduce OHC
uptake of GTTR within 30 minutes [34]. Thus, the 30 minute
timepoint represents a good baseline of GTTR uptake with
sufficient dynamic range to observe any sound-induced modula-
tion of OHC uptake of GTTR fluorescence.
Aminoglycoside uptake by hair cells
We observed that chronic moderate sound exposure can increase
hair cell uptake of GTTR or gentamicin. Variance of OHC
fluorescent intensity in control (non-sound exposed) cochleae with
30 minute systemic GTTR exposure was lower than in gentamicin-
immunolabeled OHCs (compare Fig. 1I with Fig. 2C). The
coefficient of variation of control mice in Fig. 1 was 0.13, and
0.33 for control mice in Fig. 2 (gentamicin immunofluorescence).
The difference in variance is statistically significant (f-test,
p,0.0001) if the distributions are assumed normal. This difference
is likely a result of the intrinsic variability inherent in immunopro-
cessing tissues through two stages of antigen-antibody reaction.
Nonetheless, chronic sound exposure robustly increased the
fluorescencesignalbyeithermethod.However,GTTRispreferable
for differential testing of individual experimental variables over
gentamicin immunolabeling due to its consistent dose-intensity
relationships compared to immunofluorescence (see Figure S2)[26].
Aminoglycosides severely attenuate the permeation kinetics of
K
+ and Ca
2+ through MET channels while simultaneously slowly
permeating through the channel itself [23,24]. Several studies have
reported that dihydrostreptomycin and GTTR enter hair cells
through MET channels [24,26,35]. Our acute experimental data
show that sound exposure does not directly increase OHC uptake
of aminoglycosides through the MET channels in vivo, which fits
with the hypothesis that the open probability of OHC MET
channels remains relatively constant, whether at rest or during
stimulation [36].
Prolonged, and/or intense sound exposure that induces TTS
increased OHC uptake of gentamicin in vivo. One hypothesized
mechanism for TTS is the breaking of stereociliary tip-links that
gate the MET channels [37]. If this occurs in vivo, then the
decoupled MET channels are unlikely to be responsible for
increased OHC uptake of gentamicin during TTS. This suggests
that sound trauma-enhanced uptake of aminoglycosides by OHCs
occurs by a different mechanism, activated by prolonged sound
exposure, and/or other pathologies induced in hair cells or the
stria vascularis.
Strial blood-labyrinth barrier and gentamicin trafficking
Sound-induced damage in the cochlea is not limited to the
organ of Corti; reversible pathological changes also occur in the
stria vascularis, including modulation of cochlear blood flow
[29,30], induction of micro-ischemia, and changes in vascular
permeability [10,25]. The basal region of sound-exposed cochleae
frequently exhibited changes in vessel diameter and increased
loading of GTTR or gentamicin in a subset of marginal cells, after
chronic moderate or intense sound exposure. These phenomena
suggest that marginal cells can behave heterogeneously, in terms of
aminoglycoside uptake, after acoustic overstimulation. These
drug-loaded marginal cells appeared to be exclusively localized
over strial capillaries, and imply increased permeability of the strial
blood-labyrinth barrier (BLB) that enabled enhanced drug
trafficking into marginal cells. This sound-enhanced strial
permeability (or micro-leakage) is not restricted to aminoglyco-
sides, and has also been observed for other fluorescently-labeled
proteins [38]. Regardless, once in marginal cells, which have a
+10 mV potential greater than endolymph (+80 mV) [39], the
cationic aminoglycosides would passively flow down the electro-
chemical gradient into endolymph and subsequently into hair cells
(270 mV) to exert its ototoxic effect [26]. Thus, the effect of
acoustic trauma can be similar to loop diuretics, which also
increase aminoglycoside uptake by marginal cells and hair cells
[40].
Prominent vasodilation was observed immediately after chronic
sound exposure (Fig. 4). It is possible that only large variations in
vessel diameter can be reliably identified after cardiac perfusion
and fixation. Although fixation may induce variation in strial
capillary lumenal diameter, this was not observed in control
tissues. Increased capillary lumenal diameters following noise
exposure and fixation have been reported previously [41] and by
casting techniques [42]. Intriguingly, vasodilation is not a
prerequisite of sound-enhanced trans-strial trafficking. Enhanced
trans-strial trafficking was also observed after recovery from
sound-induced transient vasodilation (Fig. 5). This likely implicates
a molecular mechanism is involved in enhanced trafficking of
aminoglycosides.
TTS-enhanced trafficking of aminoglycosides across the strial
BLB would presumably increase drug levels in endolymph, and it
is this increased endolymph level that contributes to the observed
increase in aminoglycoside uptake by hair cells. This effect would
occur independently of sound stimulation itself since the open
probability of the MET channel is hypothesized to remain
relatively constant at rest or during stimulation [36]. Nonetheless,
any spatio-temporal correlation of increased marginal cell loading
of gentamicin, and uptake by hair cells in the proximity requires
further study with better anatomical resolution.
C57Bl/6 mice are known for early onset of presbycusis after
reaching three months of age [43]. Our subjects were 4–7 weeks of
age, prior to the early onset of presbycusis in these mice, which
were also used in prior murine studies using GTTR [3,26,28,44].
Nonetheless, the stria vascularis and endolymphatic potentials
from other strains of mice, such as CBA, may be more vulnerable
by acoustic trauma [45]. Determining whether these murine
Figure 4. Prolonged, moderate sound exposure increases gentamicin uptake in a subpopulation of cells in the stria vascularis. In
non-sound-exposed strial tissues (A, C and E), moderate gentamicin immunofluorescence was observed in marginal cells (A, asterisks), with more
intense fluorescence in the strial vasculature (C). After prolonged sound exposure (18 hours over 3 days, WBN 86 dB SPL; B, D and F), a subpopulation
of marginal cells showed increased gentamicin immunofluorescence compared to adjacent marginal cells (B, asterisks, normal region) and non-
sound-exposed marginal cells (A). D: The strial vasculature below the subpopulation of intensely-labeled marginal cells displayed reduced gentamicin
immunofluorescence (c) compared to strial capillaries below marginal cells with baseline levels of gentamicin immunolabeling (d), or non-sound-
exposed strial capillaries (C). Scale bar =20 mm, fits all image panels. E: Plot profiles of lines a and b delineated in (C), showing the regular diameters
of blood vessels without sound exposure. F: Plot profiles of lines c and d delineated in (D), showing representative vasodilation and reduced
endothelial fluorescence in capillaries below the intensely labeled marginal cells following sound exposure. Bars above fluorescent traces depict the
diameter of capillary of interest. G: Sound-induced vasodilation in capillaries below intensely labeled marginal cells, but not in adjacent regions with
marginal cells with baseline levels of gentamicin immunofluorescence (***p,0.001). Error bar is s.d. n.s.= not significant.
doi:10.1371/journal.pone.0019130.g004
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cosides in stria vascularis during sound exposure, and display more
potent sound and drug synergism, requires further study. In
addition, it is unclear why of the large inter-animal variation on
the effect of chronic sound exposure. A consistent mouse model
harboring sound-induced (and/or age-induced) strial micro-
ischemia will be advantageous for ototoxicity research, and
provide opportunities to investigate any correlation between
sound-induced strial micro-ischemia and enhanced drug uptake
by hair cells. Our ultimate goal is to develop clinical strategies that
maintain the integrity of the strial BLB and reduce aminoglycoside
uptake by the cochlea during, or more frequently following sound-
induced damage within the cochlea after blast or percussive noise
exposure.
Figure 5. Intense sound exposure, followed by 18 hours recovery also increases GTTR uptake in the stria vascularis. In non-sound
exposed strial tissues (A and C), moderate GTTR fluorescence was observed in marginal cells (A, asterisks) and intra-strial cells (C), with most intense
GTTR fluorescence in the strial vasculature. Scale bar =20 mm, fits all image panels. In intense-sound exposed tissues (6 hours, OBN 100 dB SPL, 18-
hour recovery; B and D), a subset of marginal cells show increased GTTR fluorescence compared to adjacent marginal cells (B, asterisks), and marginal
cells from non-sound exposed cochleae (A, asterisks). Directly below the intensely fluorescent marginal cells in (B), cells in the intra-strial layer also
exhibited increased GTTR fluorescence. E: After 18 hours of recovery, no vasodilation (increase in vessel diameter) was observed, in the strial
vasculature from either sound or non-sound-exposed cochleae (stressed: blood vessels from strial regions with enhanced uptake of GTTR in sound
exposed cochleae; normal, blood vessels from strial regions with normal uptake of GTTR in sound-exposed cochleae). Error bar is s.d.
doi:10.1371/journal.pone.0019130.g005
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Conjugation and purification of GTTR
Gentamicin-Texas Red conjugate (GTTR) was produced as
followed: 20% gentamicin (G-1264, Sigma, St. Louis, MO) in
K2CO3 (100 mM, pH=10) and 1% Texas Red (TR) succinimidyl
esters (T6134, Invitrogen, Carlsbad, CA) in anhydrous N,N-
dimethyl formamide were mixed in ratio of 212:45 (v:v), and
agitated together for one week at room temperature prior to
purification. This protocol minimized the possibility of over-
labeling individual gentamicin molecules with more than one TR
molecule, and ensured the polycationic nature of the conjugate
(GTTR). The reaction mixture was then diluted with 100 ml 5%
Glacial acetic acid (GAA), and loaded onto pre-activated C-18
columns (Burdick and Jackson, Muskegon, MI) to purify the
conjugate using reversed phase chromatography. Each C-18
column was activated by pre-rinsing with 5 ml MeOH and 10 ml
5% GAA. Unconjugated gentamicin was eluted using 100 ml 5%
GAA; subsequently, unconjugated TR was eluted by rinsing with
MeOH. To elute purified GTTR, each column was rinsed with
3 ml chloroform:MeOH:NH3 (30:41:30). GTTR solutions from
multiple C-18 columns were pooled, aliquoted, lyophilized, and
stored desiccated in the dark at 220uC. The amount of GTTR in
each aliquot was calculated from the conjugation efficiency, and
verified by determining the fluorescence intensity for an aliquot
from each batch using a fluorimeter, and sample aliquots with
known concentrations.
Animal treatment, noise exposure and tissue preparation
Juvenile C57Bl/6 mice (4 to 7 weeks old) with positive Preyer’s
reflex were anesthetized with ketamine (65 mg/kg) and xylazine
(13 mg/kg) intra-peritoneally (i.p.). Two mg/kg GTTR (gentami-
cin base in PBS, pH 7.4) or 200 mg/kg gentamicin in PBS,
pH 7.4, was administered i.p. prior to, during or after sound
exposure, depending on experimental design. The care and use of
all animals reported in this study were approved by the Animal
Care and Use Committee of Oregon Health & Science University
(IACUC approval #IS00000351).
During prolonged or concurrent open field sound exposure, mice
were housed in a custom-made cage with free access to food and
water. The duration of sound exposure was either 3 or 6 hours at
100 dB SPL, or 18 hours over 3 days at 86 SPL. The cage was
placed in the center of a sound proof chamber (Industrial Acoustic
Company, New York, NY) with a total of 14 low, middle, and high
frequency range loud speakers mounted on the slanted walls to
achieveproduction of uniform sound fields with frequencies ranging
from 20 Hz to 48 kHz. In-house developed software was used to
flatten the speakers’ acoustic response during production of limited
and wide band noise (WBN) stimuli. A quarter-inch microphone
(Bru ¨el & Kjær, Denmark) located proximately above the animal
housing, was capable of measuring the sound level in real time.
Closed sound delivery was only used for acute concurrent sound
and drug exposure. Mice were anesthetized and systemically-
administered with either GTTR or gentamicin at doses described
above, at the beginning of 30-min concurrent sound exposure. A
sound delivery tube was sealed into the left ear of anesthetized
animals. An inner tube within the sound delivery tube was
connected to a calibration microphone (ER-10B, Etymotic
Research, Inc, Elk Grove Village, IL) for real time sound level
monitoring. Sound level was fixed at 76 or 100 dB SPL. Only the
left ears were exposed to an OBN centered at 12 kHz, while the
right ears served as controls.
After sound exposure, deeply-anesthetized mice were promptly
cardiac-perfused with PBS, then 4% formaldehyde. Cochleae from
GTTR-treated mice were excised and post-fixed in 4% formal-
dehyde for one hour, then treated with Triton X-100 (0.5%) for
30 min. Gentamicin-treated cochleae were excised and post-fixed
in 4% formaldehyde plus 0.5% Triton X-100 overnight, followed
by immunolabeling (described below). All tissues were washed,
counter-labeled with Alexa-488-conjugated phalloidin to assess
hair bundle integrity, rinsed, and post-fixed with 4% formaldehyde
[46]. GTTR or gentamicin (immuno)fluorescence in hair cells was
documented from wholemounts of cochlear coils as described
previously [26,44].
Auditory brainstem responses (ABRs) to pure tones was used to
ensure normal cochlear function prior to each experiment, and
conducted as described earlier [47]. Briefly, each ear of
anesthetized mice was stimulated individually with a closed tube
sound delivery system sealed into the ear canal. The ABR to 1 ms
rise-time tone burst stimuli at 8, 16 and 32 kHz, with 5 dB steps,
was recorded and thresholds obtained for each ear. Only animals
with normal bilateral ABR thresholds were used.
Gentamicin immunofluorescence
Gentamicin-treated cochleae were immunoblocked in 10% goat
serum in PBS for 30 minutes and then incubated with 5 mg/ml
mouse monoclonal (Fitzgerald Industries, Concord, MA) genta-
micin antisera for 2 hours. After washing with 1% goat serum in
PBS, specimens were further incubated with 20 mg/ml Alexa-488-
conjugated goat anti-mouse antisera (Molecular Probes, Eugene,
OR) for one hour, washed three times, counter-labeled with
Alexa-568-conjugated phalloidin, washed three times, and post-
fixed with 4% formaldehyde for 15 minutes [46]. A subset of
tissues were counter-labeled with 0.5 mg/ml DAPI nucleic acid
stain (Molecular Probes, Eugene, OR) for 5 minutes prior to
rinsing and post-fixation. For immunocytochemical controls,
primary antiserum was omitted or replaced with gentamicin-
adsorbed antisera and immunoprocessed as above.
Imaging and data analysis
Specimens were whole-mounted in VectaShield (Vector Labs,
Burlingame, CA) and observed using a Bio-Rad MRC 1024 ES
laser scanning confocal system attached to a Nikon Eclipse TE300
inverted microscope. Fluorescent emissions were collected sequen-
tially. For each set of experiments, all specimens in each group of
experimental and control tissues were imaged at the same laser
intensity and gain settings. Images from each experiment were
identically prepared using Adobe Photoshop. Samples labeled with
DAPI were imaged using an Olympus IX81 inverted microscope
fitted with an Olympus Fluoview FV1000 (Japan) confocal laser
microscope system.
For statistical analysis, GTTR or gentamicin (immuno)fluores-
cence intensity values in outer hair cell (OHC) cuticular plate
region, from single optical sections were obtained by using the
pixel histogram function (ImageJ, NIH), after removal of
intercellular and extraneous tissue pixels using Photoshop
[26,48]. The cuticular plate region of OHCs had the highest
level of GTTR fluorescence and was set as the region of interest
(ROI) to be compared across experimental conditions (Figure S3).
Two major regions along the murine basilar membrane of two and
half turns were imaged. One was at the junction of the 1
st and the
2
nd turns, referred to ‘‘middle coil’’, the other was towards to the
end of 2
nd turn before reaching the more calcified hook region,
referred to ‘‘basal coil’’. Mann-Whitney nonparametric tests or
paired t-tests, depending upon experimental design, were
performed between sound-exposed and non-sound-exposed co-
chleae at each cochlear section to identify any statistically
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Supporting Information
Figure S1 Prior prolonged sound exposure increased
GTTR uptake in OHCs. GTTR (2 mg/kg) was injected i.p.
during the final 30 minutes of an 18-hour WBN exposure over 3
days (6 hours per day, 86 dB SPL). The fluorescence intensity of
the cuticular plate region of each OHC was scored from each
confocal stack. Four stacks were imaged from each animal. Two
sites were from the middle coil (circle) and 2 sites were from the
basal coil (square). OHCs exhibited robust increase in GTTR
fluorescence after prior prolonged sound exposure (n=3),
compared to control OHCs (n=2). Horizontal lines depict the
group mean of fluorescence intensity. Solid line: middle coil;
dashed line: basal coil. The Mann-Whitney nonparametric test
indicated that prolonged sound exposure exerted a statistically
significant effect on GTTR fluorescence in OHC cuticular plates
in both middle coil (p,0.001) and basal coil (p,0.05) locations
compared to control cuticular plates.
(TIF)
Figure S2 The dose-intensity relationship of GTTR or
gentamicin (immuno)fluorescence. The intensity of GTTR
and monoclonal gentamicin (immuno)fluorescence is dose-depen-
dent, unlike that for the polyclonal antibody. The panels on the
right display the immunofluorescence emission of different
gentamicin doses using monoclonal gentamicin antisera on
Madin-Darby canine kidney (MDCK) cells. Scale bar =20 mm.
(TIF)
Figure S3 Greater GTTR fluorescence in the cuticular
plate region of OHCs. A: Representative xz section image of
organ of Corti from the basal cochlear turn of a GTTR-treated
mouse. Prominent GTTR fluorescence (red) was observed in hair
cells (OHCs, *; IHC, #), compared to surrounding supporting
cells and structures. Green: phalloidin. SL: spiral limbus. TC:
Tunnel of Corti. Scale bar =20 mm. B: Representative variation
in GTTR fluorescence in the longitudinal axis of individual OHCs
from the same cochlea, at various cochlear locations. Three to four
OHCs per location were selected. More intense GTTR fluores-
cence occurred in the cuticular plate region (CP, gray area)
regardless of cochlear location for individual OHCs. OHCs from
more basal regions of the cochlea show the most intense GTTR
fluorescence. HB: hair bundle.
(TIF)
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